• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UBFC:TH

288.0200 EUR 7.0200 2.50%

As of 12:41:29 ET on 04/17/2014.

Snapshot for UBS Lux Equity Fund - Biotech USD (UBFC)

Open: 288.0200 High - Low: 288.0200 - 288.0200 Primary Exchange: Tradegate
Volume: 40 52-Week Range: 240.0700 - 366.4400 Beta vs NSESWRLD: -

ETF Chart for UBFC

No chart data available.
  • UBFC:TH 288.0200
  • 1D
  • 1M
  • 1Y
281.0000
Interactive UBFC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBFC

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: 1996-10-18 Telephone: 352-44-10-10-1 Tel
Managers: NATHALIE LOTSCHER PETRUS
Web Site: www.ubs.com

Fundamentals for UBFC

NAV -
Assets (M) (on 2014-04-16) 953.1153
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UBFC

No dividends reported

Performance for UBFC

1-Month -14.56% 1-Year +20.59%
3-Month -11.53% 3-Year +25.37%
Year To Date +0.82% 5-Year -
Expense Ratio 2.09

Top Fund Holdings for UBFC

Filing Date: 02/28/2014
Name Position Value % of Total
Gilead Sciences Inc 1,415,600 117,197,524 9.296%
Biogen Idec Inc 322,900 110,005,572 8.725%
Amgen Inc 750,114 93,029,138 7.379%
Celgene Corp 447,160 71,880,970 5.701%
Regeneron Pharmaceuticals Inc 207,100 68,860,750 5.462%
BioMarin Pharmaceutical Inc 764,000 61,884,000 4.908%
Alexion Pharmaceuticals Inc 337,800 59,723,040 4.737%
Incyte Corp Ltd 784,800 50,431,248 4.000%
Vertex Pharmaceuticals Inc 610,100 49,332,686 3.913%
Medivation Inc 634,800 45,648,468 3.621%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil